Table of Contents

<< Previous Issue

Mar 2011 (Vol: 2011, Issue: 3)

Next Issue >>

Download pdf of entire issue

Section: Licensing
Astellas Gains Ex-Asia Rights to Tivozanib from AVEO in Potential US$1.4 B Deal Published: 7 Mar-2011
By: Heather Cartwright
Abstract Fulltext:
Cell Therapeutics Expands its Late-Stage Oncology Pipeline with Chroma Therapeutics’ Tosedostat Published: 28 Mar-2011
By: Heather Cartwright
Abstract Fulltext:
Section: Mergers & Acquisitions
Genzyme Finally Agrees to US$20.1 B Plus CVR Takeover by Sanofi-aventis Published: 2 Mar-2011
By: Heather Cartwright
Abstract Fulltext:
Gilead Continues its Diversification Strategy with Acquisition of Calistoga Pharmaceuticals Published: 9 Mar-2011
By: Heather Cartwright
Abstract Fulltext:
Forest Laboratories Agrees to Acquire Clinical Data for US$1.2 B Upfront Published: 14 Mar-2011
By: Heather Cartwright
Abstract Fulltext:
Kyowa Hakko Kirin Makes Takeover Bid for ProStrakan to Expand in Foreign Markets Published: 17 Mar-2011
By: Heather Cartwright
Abstract Fulltext:
Daiichi Sankyo Targets US Oncology Market with US$935 M Plexxikon Acquisition Published: 17 Mar-2011
By: Heather Cartwright
Abstract Fulltext:
Section: Research & Development
Lycera and Merck & Co. to Develop Autoimmune Disease Drugs Targeting Th17 Cells Published: 21 Mar-2011
By: Heather Cartwright
Abstract Fulltext:
Epizyme Signs its Second Major Deal of 2011 Published: 24 Mar-2011
By: Heather Cartwright
Abstract Fulltext:

Login

Login

Username:

Password:

Keep me logged in

Login Problems? Subscribe

IQVIA™ Pharma Deals: PharmaDeals Review: Table of Contents